Kiniksa Pharmaceuticals International Plc (KNSA)
15.75 x 1 28.00 x 1
Pre-market by (Cboe BZX)
21.47 +0.10 (+0.47%) 04/28/25 [NASDAQ]
15.75 x 1 28.00 x 1
Pre-market 21.47 unch (unch) 16:00 ET
for Mon, Apr 28th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -43,193 | 14,084 | 183,363 | -157,924 | -161,381 |
| Depreciation Amortization | 1,695 | 2,341 | 2,402 | 2,355 | 2,405 |
| Income taxes - deferred | 8,132 | -33,788 | -185,495 | 11 | 4,361 |
| Accounts receivable | -20,458 | -8,606 | -8,675 | -3,910 | N/A |
| Accounts payable and accrued liabilities | -6,306 | 347 | 6,031 | 1,366 | -4,969 |
| Other Working Capital | 24,809 | 1,350 | -22,575 | 689 | -4,315 |
| Other Operating Activity | 61,010 | 37,573 | 30,756 | 31,115 | 27,367 |
| Operating Cash Flow | $25,689 | $13,301 | $5,807 | $-126,298 | $-136,532 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 37,924 | -29,427 | -8,064 | 149,050 | -23,161 |
| PPE Investments | -252 | -130 | -14 | -415 | -283 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -20,000 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -20,000 | 0 |
| Investing Cash Flow | $37,672 | $-29,557 | $-8,078 | $128,635 | $-23,444 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 17,250 | 3,701 | 3,417 | 5,885 | 228,222 |
| Other Financing Activity | -4,984 | -2,206 | -901 | 0 | -1,136 |
| Financing Cash Flow | $12,266 | $1,495 | $2,516 | $5,885 | $227,086 |
| Beginning Cash Position | 107,954 | 122,715 | 122,470 | 114,248 | 47,138 |
| End Cash Position | 183,581 | 107,954 | 122,715 | 122,470 | 114,248 |
| Net Cash Flow | $75,627 | $-14,761 | $245 | $8,222 | $67,110 |
| Free Cash Flow | |||||
| Operating Cash Flow | 25,689 | 13,301 | 5,807 | -126,298 | -136,532 |
| Capital Expenditure | -277 | -130 | -105 | -415 | -283 |
| Free Cash Flow | 25,412 | 13,171 | 5,702 | -126,713 | -136,815 |